Dysplasia of prostate. Dysplasia of Prostate, Low grade dysplasia
Conditions
Interventions
Intervention 1: Intervention Group: intrarectal administration of 50 gr lidocaine gel (2%) produced by Sina daro company and 50 mcg fentanyl produced by Rasht-Iran company. Intervention 2: Control Gro
Treatment - Drugs
Prevention
Intervention Group: intrarectal administration of 50 gr lidocaine gel (2%) produced by Sina daro company and 50 mcg fentanyl produced by Rasht-Iran company.
Control Group: intrarectal administration of 50 gr lidocaine gel 2% prodused by Sina daro company.
Sponsors
Vice chancellor for research of Tehran University of Medical Sciences
Eligibility
Sex/Gender
Male
Age
30 Years to 80 Years
Inclusion criteria
Inclusion criteria: Inclusion criteria: Patients candidate for prostate biopsy; Minimum weight 40 kg Exclusion criteria: uncontrolled blood pressure; sensitivity to local anesthetics; advanced heart, renal or hepatic disease; opioid addiction.
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Pain. Timepoint: Before and During Biopsy. Method of measurement: VAS Score.;Blood Pressure. Timepoint: Before and During Biopsy. Method of measurement: Monitoring.;Heart Rate. Timepoint: Before and During Biopsy. Method of measurement: Pulse Oximetry. | — |
Secondary
| Measure | Time frame |
|---|---|
| Level of consciousness. Timepoint: Before and during biopsy. Method of measurement: Miller Score. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactDr.Farsad Imani
Tehran University of Medical Sciences
Outcome results
None listed